Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 83.00
Ask: 88.00
Change: 1.50 (1.79%)
Spread: 5.00 (6.024%)
Open: 84.00
High: 85.50
Low: 84.00
Prev. Close: 84.00
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealings

28 Jul 2021 14:40

RNS Number : 7981G
Eco Animal Health Group PLC
28 July 2021
 

28 July 2021

 

 

ECO Animal Health Group PLC

("ECO" or "the Company")

 

Directors Dealings

 

ECO Animal Health Group plc was notified today that on 28 July 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.

 

Dr Andrew Jones, Non-Executive Chairman of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Dr Jones' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

 

Dr Frank Armstrong, a Non-Executive Director of the Company, purchased 3,000 Ordinary Shares at a price of 324 pence per Ordinary Share. As a result of this transaction, Dr Armstrong's total shareholding in the Company comprises 3,000 Ordinary Shares, representing approximately 0.004 per cent. of the Company's issued share capital.

 

Christopher Wilks, Chief Financial Officer of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

For further information please contact:

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

Iqra Amin

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

 

 

PDMR Notification

The notification below is made in accordance with the requirements of MAR

Acquisition of Ordinary Shares

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Andrew Jones

 

2.

Reason for the notification

a.

Position/status

Non-Executive Chairman

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Frank Armstrong

 

2.

Reason for the notification

a.

Position/status

Non-Executive Director

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

324.00p

3,000

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Wilks

 

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADXPAADFEFA
Date   Source Headline
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
26th Aug 20221:13 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
22nd Aug 20227:00 amRNSRevised Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.